Latest News
Beyond latent and active tuberculosis
Researchers from the MRC Clinical Trials Unit at UCL have published the first study to systematically review how scientists and medical professionals characterise the different stages of tuberculosis (TB), beyond the binary of latent or active.
A new toolkit for checking simulation studies
Our methodologists have published an article with guidance on how to check the quality of simulation studies to help prevent errors.
First effective treatment to prevent multidrug-resistant TB
An oral antibiotic taken once daily for six months can substantially reduce the risk of developing multidrug-resistant (MDR) tuberculosis (TB) in both children and adults, according to two landmark clinical trials.
Taking PrEP improves wellbeing
Qualitative data from PROUD study provides first look at the psychological and social impacts of taking oral PrEP among gay men in England.
MRC CTU at UCL and collaborators at the International Society of Blood Transfusion 2023 conference
Researchers from the MRC Clinical Trials Unit at UCL and our partner institutes will share highlights from our TRACT blood transfusion clinical trial.